Lucette Doessegger

489 total citations
12 papers, 340 citations indexed

About

Lucette Doessegger is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lucette Doessegger has authored 12 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Cardiology and Cardiovascular Medicine and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lucette Doessegger's work include Cardiac electrophysiology and arrhythmias (3 papers), Effects and risks of endocrine disrupting chemicals (2 papers) and Computational Drug Discovery Methods (2 papers). Lucette Doessegger is often cited by papers focused on Cardiac electrophysiology and arrhythmias (3 papers), Effects and risks of endocrine disrupting chemicals (2 papers) and Computational Drug Discovery Methods (2 papers). Lucette Doessegger collaborates with scholars based in Switzerland, United States and Belgium. Lucette Doessegger's co-authors include Bharat Thakrar, Thomas P. Singer, Georg Schmitt, Barbara Lenz, M. Csató, Holger Fischer, Michael E. Dunn, Wanping Geng, Joerg Herrmann and Hanns‐Christian Mahler and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Medicinal Chemistry and Journal of Pharmaceutical Sciences.

In The Last Decade

Lucette Doessegger

12 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lucette Doessegger Switzerland 8 108 67 62 59 55 12 340
Athar Khalil Lebanon 13 177 1.6× 10 0.1× 34 0.5× 37 0.6× 48 0.9× 37 542
Jiraphun Jittikoon Thailand 14 133 1.2× 16 0.2× 25 0.4× 13 0.2× 82 1.5× 51 614
Napatrupron Koomdee Thailand 15 61 0.6× 50 0.7× 11 0.2× 26 0.4× 76 1.4× 28 551
Shiori Haga Japan 8 120 1.1× 9 0.1× 87 1.4× 29 0.5× 71 1.3× 9 694
Ki‐Eun Hwang South Korea 15 272 2.5× 40 0.6× 10 0.2× 13 0.2× 49 0.9× 45 681
William M. Sanders United States 11 145 1.3× 21 0.3× 27 0.4× 18 0.3× 8 0.1× 19 460
Michael Elsässer Germany 10 84 0.8× 17 0.3× 25 0.4× 19 0.3× 17 0.3× 15 276
Andrew P. Beelen United States 12 161 1.5× 7 0.1× 29 0.5× 23 0.4× 25 0.5× 35 553
Ashit Trivedi United States 9 114 1.1× 5 0.1× 53 0.9× 24 0.4× 35 0.6× 29 316
Jason M. Gow United States 11 157 1.5× 7 0.1× 20 0.3× 29 0.5× 32 0.6× 12 615

Countries citing papers authored by Lucette Doessegger

Since Specialization
Citations

This map shows the geographic impact of Lucette Doessegger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucette Doessegger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucette Doessegger more than expected).

Fields of papers citing papers by Lucette Doessegger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucette Doessegger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucette Doessegger. The network helps show where Lucette Doessegger may publish in the future.

Co-authorship network of co-authors of Lucette Doessegger

This figure shows the co-authorship network connecting the top 25 collaborators of Lucette Doessegger. A scholar is included among the top collaborators of Lucette Doessegger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucette Doessegger. Lucette Doessegger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
Wandel, Christoph, Paul Barrow, Georg Schmitt, et al.. (2016). Clinical trial considerations on male contraception and collection of pregnancy information from female partner: update. Clinical and Translational Medicine. 5(1). 23–23. 1 indexed citations
3.
Doessegger, Lucette, et al.. (2015). Clinical development methodology for infusion‐related reactions with monoclonal antibodies. Clinical & Translational Immunology. 4(7). 87 indexed citations
4.
Doessegger, Lucette, Georg Schmitt, Barbara Lenz, et al.. (2013). Increased levels of urinary phenylacetylglycine associated with mitochondrial toxicity in a model of drug-induced phospholipidosis. Therapeutic Advances in Drug Safety. 4(3). 101–114. 13 indexed citations
5.
Doessegger, Lucette, et al.. (2012). The Potential Clinical Relevance of Visible Particles in Parenteral Drugs. Journal of Pharmaceutical Sciences. 101(8). 2635–2644. 35 indexed citations
6.
Dunn, Michael E., Tanja S. Zabka, Wanping Geng, et al.. (2012). Myocardial Mononuclear Cell Infiltrates Are Not Associated with Increased Serum Cardiac Troponin I in Cynomolgus Monkeys. Toxicologic Pathology. 40(4). 647–650. 5 indexed citations
7.
Wandel, Christoph, Georg Schmitt, Elmar Gocke, et al.. (2012). Clinical trial considerations on male contraception and collection of pregnancy information from female partners. Journal of Translational Medicine. 10(1). 129–129. 10 indexed citations
8.
Fischer, Holger, M. Csató, Lucette Doessegger, et al.. (2011). In Silico Assay for Assessing Phospholipidosis Potential of Small Druglike Molecules: Training, Validation, and Refinement Using Several Data Sets. Journal of Medicinal Chemistry. 55(1). 126–139. 34 indexed citations
9.
Dunn, Michael E., Igor Mikaelian, Steven E. Lipshultz, et al.. (2011). The Complete Pharmacokinetic Profile of Serum Cardiac Troponin I in the Rat and the Dog. Toxicological Sciences. 123(2). 368–373. 38 indexed citations
10.
Patel, Premal H., John Bothos, Joe Leigh Simpson, et al.. (2011). Safety data and patterns of progression in met diagnostic subgroups in OAM4558g; A phase II trial evaluating MetMAb in combination with erlotinib in advanced NSCLC.. Journal of Clinical Oncology. 29(15_suppl). 7604–7604. 7 indexed citations
11.
Thakrar, Bharat, et al.. (2007). Detecting signals of drug–drug interactions in a spontaneous reports database. British Journal of Clinical Pharmacology. 64(4). 489–495. 84 indexed citations
12.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Athar Khalil Breakdown of academic impact, for papers by Jiraphun Jittikoon Breakdown of academic impact, for papers by Napatrupron Koomdee Breakdown of academic impact, for papers by Shiori Haga Breakdown of academic impact, for papers by Ki‐Eun Hwang Breakdown of academic impact, for papers by William M. Sanders Breakdown of academic impact, for papers by Michael Elsässer Breakdown of academic impact, for papers by Andrew P. Beelen Breakdown of academic impact, for papers by Ashit Trivedi Breakdown of academic impact, for papers by Jason M. Gow
Rankless by CCL
2026